Lv3
244 积分 2022-02-24 加入
Emerging EGFR-Targeted Therapy in Head and Neck Cancer
3天前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non–Small Cell Lung Cancer
4天前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy: Current Approvals and Emerging Evidence
4天前
已完结
Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With EGFR Variant
4天前
已完结
Sabatolimab plus hypomethylating agents in previously untreated patients with higher-risk myelodysplastic syndromes (STIMULUS-MDS1): a randomised, double-blind, placebo-controlled, phase 2 trial
4天前
已完结
The Next Decade of Immune Checkpoint Therapy
12天前
已完结
The tumor microenvironment’s role in the response to immune checkpoint blockade
12天前
已完结
Development of Immunotherapy Combination Strategies in Cancer
12天前
已完结
Becotatug Vedotin in Patients with Recurrent or Metastatic Squamous Cell Carcinoma of Head and Neck: A Multicenter, Phase IIa Trial
15天前
已完结
Neoadjuvant nivolumab plus carboplatin and paclitaxel in patients with locally advanced resectable squamous cell carcinoma of the head and neck: a phase II, single-arm trial
17天前
已完结
皖公网安备34019202002308
